SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-24-050010 from BioSig Technologies, Inc. (BSGM) (CIK 0001530766) (STEX)

BioSig Technologies, Inc. (BSGM) (CIK 0001530766)
Date: Dec. 13, 2024 · CIK: 0001530766 · Accession: 0001493152-24-050010

AI Filing Summary & Sentiment

File numbers found in text: 333-276298

Date
Dec. 13, 2024
Author
Chief
Form
CORRESP
Company
BioSig Technologies, Inc. (BSGM) (CIK 0001530766)

Letter

BioSig Technologies, Inc.

Wilshire Blvd, Suite 745

Los Angeles, California 90025

December 13, 2024

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Washington, D.C. 20549

Attention: Robert Augustin

Re: BioSig Technologies, Inc.

Registration Statement on Form S-3

File No. 333-276298 (the “Registration Statement”)

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, BioSig Technologies, Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective at 4:30 p.m., Eastern Time, on December 17, 2024, or as soon thereafter as practicable.

Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Sichenzia Ross Ference Carmel LLP, attention: Barrett DiPaolo, Esq. at (646) 810-2173.

Very
truly yours,
BIOSIG
TECHNOLOGIES, INC.

Show Raw Text
CORRESP
1
filename1.htm

BioSig
Technologies, Inc.

12424
Wilshire Blvd, Suite 745

Los
Angeles, California 90025

December
13, 2024

VIA
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

Washington,
D.C. 20549

Attention:
Robert Augustin

    Re:
    BioSig
    Technologies, Inc.

    Registration
    Statement on Form S-3

    File
    No. 333-276298 (the “Registration Statement”)

    Request
    for Acceleration

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under
the Securities Act of 1933, as amended, BioSig Technologies, Inc. (the “Company”) hereby respectfully requests
acceleration of the effective date of the Registration Statement so that it may become effective at 4:30 p.m., Eastern Time, on December
17, 2024, or as soon thereafter as practicable.

Should
any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Sichenzia
Ross Ference Carmel LLP, attention: Barrett DiPaolo, Esq. at (646) 810-2173.

    Very
    truly yours,

    BIOSIG
    TECHNOLOGIES, INC.

    By:
    /s/
    Anthony Amato

    Anthony
    Amato

    Chief
    Executive Officer